DeepMind's Ultra-Powerful AI for Genome Mapping Wows Scientists

Google’s AlphaGenome 2 zooms in on the cellular roots of disease

A graphic representing Google’s AlphaGenome Atlas. | Image: Google Researchers at Google DeepMind have unveiled a new AI model designed to unravel how changes in our DNA affect different cells, giving scientists a more detailed view of a notoriously difficult problem that could hold important clues to the causes of disease - and point the way to new treatments. AlphaGenome 2 is the successor to DeepMind's genome-predicting AI model AlphaGenom…

DeepMind's ultra-powerful AI for genome mapping wows scientists

Nature, Published online: 11 November 2026; doi:10.1038/d41586-026-03673-0AlphaGenome 2 can predict the types of cells where a DNA variant is likely to act.

Google DeepMind launches AlphaGenome 2 to predict DNA effects in single cell types

Genomics Limited, led by Peter Donnelly, is already folding the model into its Mystra platform. DeepMind says it finds causal variants 30% of the time against 16% before, but weights are unreleased and commercial access is a private preview.

Google DeepMind Unveils AlphaGenome 2 to Bridge Single-Cell Biology and Human Genetics

Google DeepMind officially launched AlphaGenome 2, a major upgrade to its foundational DNA sequence model that connects broad tissue-level regulation down to individual cell types and cell states. The model was trained on more than 100 million individual cell profiles across 68 distinct tissues, transforming static biological cell atlases into a powerful predictive engine for […] The post Google DeepMind Unveils AlphaGenome 2 to Bridge Single-Ce…